Literature DB >> 1390620

Drug-induced Creutzfeldt-Jakob like syndrome.

P F Finelli1.   

Abstract

A patient with progressive neurological deterioration characterized by cognitive impairment, myoclonus, Parkinson's syndrome, an abnormal electroencephalogram and fasciculations was considered for brain biopsy for suspected Creutzfeldt-Jakob disease. Complete clinical recovery followed discontinuation of lithium and nortriptyline. Awareness of this unusual drug-induced Creutzfeldt-Jakob like syndrome can avoid costly, invasive and unnecessary investigative procedures.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1390620      PMCID: PMC1188422     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  9 in total

1.  A Creutzfeldt-Jakob-like syndrome due to polypharmacy.

Authors:  A J Waldman
Journal:  South Med J       Date:  1990-12       Impact factor: 0.954

2.  Reversible Creutzfeldt-Jakob like syndrome induced by lithium plus levodopa treatment.

Authors:  E Broussolle; A Setiey; Y Moene; M Trielett; G Chazot
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

3.  A Creutzfeldt-Jakob like syndrome due to lithium toxicity.

Authors:  A Primavera; G Brusa; M G Poeta
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

4.  Another case of Creutzfeldt-Jakob like syndrome due to antidepressant toxicity.

Authors:  J Foerstl; F Hohagen; W Hewer; B Pohlmann-Eden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

5.  Creutzfeldt-Jakob disease without periodic sharp wave complexes: a clinical, electroencephalographic, and pathologic study.

Authors:  D W Zochodne; G B Young; R S McLachlan; J J Gilbert; H V Vinters; J C Kaufmann
Journal:  Neurology       Date:  1988-07       Impact factor: 9.910

6.  Periodic sharp waves in baclofen-induced encephalopathy.

Authors:  J T Hormes; E E Benarroch; M Rodriguez; D W Klass
Journal:  Arch Neurol       Date:  1988-07

7.  Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases.

Authors:  P Brown; F Cathala; P Castaigne; D C Gajdusek
Journal:  Ann Neurol       Date:  1986-11       Impact factor: 10.422

Review 8.  Lithium carbonate intoxication. A case report and review of the literature.

Authors:  M Simard; B Gumbiner; A Lee; H Lewis; D Norman
Journal:  Arch Intern Med       Date:  1989-01

9.  A Creutzfeldt-Jakob like syndrome due to lithium toxicity.

Authors:  S J Smith; R S Kocen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

  9 in total
  6 in total

Review 1.  Drug-induced dementia. Incidence, management and prevention.

Authors:  J M Starr; L J Whalley
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

2.  Reversible lithium neurotoxicity: review of the literatur.

Authors:  Ivan Netto; Vivek H Phutane
Journal:  Prim Care Companion CNS Disord       Date:  2012

Review 3.  Therapies for human prion diseases.

Authors:  Peter K Panegyres; Elizabeth Armari
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

Review 4.  Another Perspective on Fasciculations: When is it not Caused by the Classic form of Amyotrophic Lateral Sclerosis or Progressive Spinal Atrophy?

Authors:  Marco Antonio Araujo Leite; Marco Orsini; Marcos R G de Freitas; João Santos Pereira; Fábio Henrique Porto Gobbi; Victor Hugo Bastos; Dionis de Castro Machado; Sergio Machado; Oscar Arrias-Carrion; Jano Alves de Souza; Acary Bulle Oliveira
Journal:  Neurol Int       Date:  2014-08-08

5.  Polypharmacy-induced cognitive dysfunction and discontinuation of psychotropic medication: a neuropsychological case report.

Authors:  Jussi Valtonen; Mira Karrasch
Journal:  Ther Adv Psychopharmacol       Date:  2020-04-28

Review 6.  Potential application of lithium in Parkinson's and other neurodegenerative diseases.

Authors:  Carol A Lazzara; Yong-Hwan Kim
Journal:  Front Neurosci       Date:  2015-10-27       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.